The effect of oral ritodrine on maternal and fetal carbohydrate metabolism.
The reported growth-promoting effects of the beta-sympathomimetic compound, ritodrine, have been investigated. The carbohydrate tolerance of eight pregnant women was found to be unaffected by treatment with oral ritodrine over a ten-week period. A further observation that the carbohydrate metabolism of the newborn infants of these women was within normal limits tends to discount possibility that any growth-promoting action ritodrine may have on the fetus is mediated through a diabetogenic effect on the mother.
D001786:Blood Glucose / Q000378:metabolism*; D005260:Female; D005312:Fetal Blood / Q000032:analysis; D005333:Fetus / Q000187:drug effects* / Q000378:metabolism; D005951:Glucose Tolerance Test; D006801:Humans; D007231:Infant, Newborn; D007328:Insulin / Q000097:blood*; D011247:Pregnancy; D011412:Propanolamines / Q000494:pharmacology*; D012312:Ritodrine / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology; D014599:Uterus / Q000098:blood supply
D001786:Blood Glucose; D007328:Insulin; D011412:Propanolamines; D013566:Sympathomimetics; D012312:Ritodrine